Clinical studies show that tirzepatide leads to, on average, larger weight loss than semaglutide, though that doesnt mean its the right choice for everyone looking to start a weight loss medication
Temporary sexual side effects during dose escalation While the long-term evidence favors improved sexual function, the short-term reality during the first weeks of tirzepatide treatment can be different
Tirzepatide dosing is not one-size-fits-all
In telogen effluvium, follicles remain viable and capable of regrowth
The trial involved 1879 patients with inadequate glycemic control on metformin monotherapy, who were randomly assigned to receive tirzepatide at doses of 5 mg, 10 mg, or 15 mg, or semaglutide at a dose of 1 mg.After 40 weeks of treatment, all doses of tirzepatide were found to be noninferior and superior to semaglutide in terms of reducing glycated hemoglobin (HbA1c) levels